[
Skip to content
]
Contact us
Login
Accessibility
Text size:
A
A
A
Site map
Search our Site
Search our site
Search
Advanced Search
Search our site
Welcome
>
News
About the EPDA
Parkinson's
Political affairs and policy
Projects
News
EPDA news
Parkinson's organisations
Medical and pharmaceutical
Research
Political and policy
All news
Archived news
Events
Media centre
Resources and publications
Research papers
Contact us
Site help
PDF basket
Site search
Site map
.
EPDA news
The challenges of Neurodegenerative Diseases in the Workplace
17 June 2013
EPDA General Assembly registration open
01 May 2013
View all EPDA news
Parkinson's organisations
The Michael J. Fox Foundation and the National Institute of Neurological Disorders and Stroke Join Forces on Parkinson's Disease
07 November 2012
The Michael J. Fox Foundation Launches $10-million Edmond J. Safra Core Programs for PD Research
04 June 2013
View all Parkinson's organisations news
Political
The challenges of Neurodegenerative Diseases in the Workplace
17 June 2013
MHRA prioritises science and research support as part of new corporate plan
11 April 2013
View all Political news
Medical and pharmaceutical
The Michael J. Fox Foundation Launches $10-million Edmond J. Safra Core Programs for PD Research
04 June 2013
Adamas Pharmaceuticals to report positive Phase 2.3 results for ADS-5102 for treatment of Levodopa-induced dyskinesia in PD
10 June 2013
View all Medical and pharmaceutical news
Research
Dopamine Induced Neurodegeneration in a PINK1 Model of Parkinson's Disease
25 May 2012
Improvements in nocturnal symptoms with ropinirole prolonged release in patients with advanced Parkinson's disease
01 January 2012
View all Research news
View ALL news >
